<DOC>
	<DOCNO>NCT00614445</DOCNO>
	<brief_summary>The purpose study determine whether Diclectin® ( doxylamine succinate USP 10 mg pyridoxine HCl 10 mg ) effective control nausea vomit pregnancy placebo .</brief_summary>
	<brief_title>The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy</brief_title>
	<detailed_description>Nausea vomit pregnancy ( NVP ) , also know `` morning sickness , '' common condition affect large percentage pregnant woman . The symptom range mild nausea severe nausea vomit woman may need hospitalize . Nausea vomit pregnancy affect woman 's quality life ability conduct daily activity . Diclectin® combination 10 mg doxylamine succinate ( antihistamine ) , 10 mg pyridoxine hydrochloride ( vitamin B6 ) delay release tablet formulation . It commercially available Canada management NVP 25 year prescribe 33 million pregnant woman . Presently , Food Drug Administration ( FDA ) approve drug market treat symptom NVP . This study test efficacy Diclectin® ( doxylamine 10 mg , pyridoxine 10 mg delayed-release formulation ) NVP . Patients enrol study receive 2 4 tablet Diclectin® placebo daily , depend symptom 14 day . Patients assess symptom nausea vomit daily use standardized questionnaire .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Doxylamine</mesh_term>
	<mesh_term>Dicyclomine , doxylamine , pyridoxine drug combination</mesh_term>
	<mesh_term>Doxylamine succinate</mesh_term>
	<mesh_term>Dicyclomine</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Vitamin B 6</mesh_term>
	<mesh_term>Pyridoxal</mesh_term>
	<criteria>The patient sign write informed consent participate study agree follow dosing instruction complete require study visit . The patient pregnant female age equal great 18 year old . The patient 's entry ultrasound indicate viable pregnancy confirm gestational age fetus 714 week anticipated time first dose study medication placebo . If ultrasound do within 4 week admission visit , result obtain , additional ultrasound necessary . The patient suffer NVP Pregnancy Unique Quantification Emesis ( PUQE ) score ≥6 . The patient respond conservative management consist dietary/lifestyle advice accord 2004 ACOG Practice Bulletin . The patient agree , multivitamin , continue current dose multivitamin duration trial . The patient plan termination pregnancy . The investigator confirm patient 's nausea vomit etiology Nausea Vomiting Pregnancy ( NVP ) . The patient gestational trophoblastic disease multifetal gestation . The patient condition antihistamine , opinion investigator , contraindicate ( epilepsy , alcoholism , glaucoma , chronic lung disease , urinary retention , heart block , etc. ) . The patient use antihistamine , anticholinergic , dopamine antagonist , serotonin antagonist , ginger , antiemetic therapy ( include acupressure , acupuncture , homeopathic remedy , medical hypnosis , relief band etc ) treat NVP previous 48 hour plan study . The patient use drug anticholinergic activity ( e.g. , tricyclic antidepressant ) . The patient take multivitamin contain 10 mg vitamin B6 , plan study . The patient take supplementary vitamin B6 addition multivitamin preparation , plan study . The patient currently drink amount alcohol . The patient condition might interfere conduct study . The patient likely unable comply study procedure inadequate cognitive skill . The patient receive investigational drug within 30 day enrollment study schedule receive investigational drug course study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Nausea</keyword>
	<keyword>Vomiting</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Hyperemesis gravidarum</keyword>
	<keyword>Pregnancy complication</keyword>
</DOC>